clinical trial · NCT04619108

Thrombosomes for Expanded Access Use

Cellphire Therapeutics, Inc.·—·no longer available

BleedingThrombosomes®

brief summary

Expanded use of Thrombosomes where a clinical trial with Thrombosomes is not an option, Cellphire may elect to provide the Sponsor/Investigator (S/I) expanded access to its investigational product, Thrombosomes.

started

—

primary completion

—

completion

—

last updated

Mar 21, 2024

full record on clinicaltrials.gov ↗

sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol